Citadel Advisors - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$864,111
-55.0%
363,072
-9.3%
0.00%
Q2 2023$1,918,266
-48.6%
400,473
-39.1%
0.00%
-100.0%
Q1 2023$3,728,553
+728.9%
657,593
+718.6%
0.00%
Q4 2022$449,842
-37.3%
80,329
-28.1%
0.00%
Q3 2022$718,000
+0.8%
111,788
-46.1%
0.00%
Q2 2022$712,000
-67.1%
207,491
-31.7%
0.00%
Q1 2022$2,162,000
-48.5%
303,677
-39.8%
0.00%
-100.0%
Q4 2021$4,200,000
+179.6%
504,232
+133.8%
0.00%
Q3 2021$1,502,000
-84.1%
215,706
-45.4%
0.00%
-100.0%
Q2 2021$9,418,000
+6.7%
394,863
-7.9%
0.00%
-50.0%
Q1 2021$8,830,000
+7.1%
428,802
+27.5%
0.00%0.0%
Q4 2020$8,242,000
+156.0%
336,371
+195.8%
0.00%
+100.0%
Q3 2020$3,219,000
+383.3%
113,718
-18.7%
0.00%
Q2 2020$666,000
+313.7%
139,845
+209.2%
0.00%
Q1 2020$161,000
-4.2%
45,228
-7.2%
0.00%
Q4 2019$168,000
+133.3%
48,748
+172.4%
0.00%
Q3 2019$72,000
-66.0%
17,897
-72.7%
0.00%
Q2 2019$212,000
+94.5%
65,639
+313.9%
0.00%
Q1 2019$109,000
-45.5%
15,858
-64.3%
0.00%
Q4 2018$200,000
-16.3%
44,429
+41.5%
0.00%
Q3 2018$239,000
+30.6%
31,400
+48.0%
0.00%
Q2 2018$183,000
-81.8%
21,217
-84.5%
0.00%
-100.0%
Q1 2018$1,005,000
-28.0%
136,924
-0.5%
0.00%0.0%
Q4 2017$1,396,000
+206.8%
137,664
+242.3%
0.00%
Q2 2017$455,000
+95.3%
40,212
+94.6%
0.00%
Q1 2017$233,000
+99.1%
20,662
+74.8%
0.00%
Q4 2016$117,000
-92.3%
11,821
-90.4%
0.00%
-100.0%
Q3 2016$1,513,000
-81.1%
123,137
-36.3%
0.00%
-85.7%
Q2 2015$8,019,000193,2260.01%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders